Education
About Us
Working with TipRanks
Follow Us
Polygiene AB (SE:POLYG)
:POLYG
Top Page
Polygiene AB
(Berlin:POLYG)
67Neutral
Polygiene AB (POLYG) vs. S&P 500 (SPY)
Market Cap
kr361.62M
Dividend YieldN/A
Average Volume (3M)8.38K
Price to Earnings (P/E)28.2
Beta (1Y)0.98
Revenue Growth38.77%
EPS GrowthN/A
CountrySE
Employees49
SectorConsumer Defensive
Sector Strength91
IndustryChemicals
Share Statistics
EPS (TTM)0.35
Shares Outstanding36,526,990
10 Day Avg. Volume4,438
30 Day Avg. Volume8,377
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Polygiene AB Business Overview & Revenue Model
Company DescriptionPolygiene AB (POLYG) is a Swedish company specializing in antimicrobial and odor-control solutions. As a leader in the textile and materials technology sector, Polygiene offers innovative treatments that prevent the growth of odor-causing bacteria and fungi. The company's core products and services are designed to enhance the hygiene and durability of textiles, apparel, and other materials, providing added value to manufacturers and consumers alike.
How the Company Makes MoneyPolygiene AB generates revenue primarily through the sale of its antimicrobial and odor-control treatments to textile and apparel manufacturers. These treatments are applied during the production process to enhance the longevity and hygiene of fabrics. The company's key revenue streams include licensing its technology to manufacturers, direct sales of treatment solutions, and partnerships with brands seeking to incorporate odor-control features into their products. Strategic collaborations with leading brands and manufacturers in various industries also contribute significantly to its earnings, allowing Polygiene to expand its market reach and influence.
Polygiene AB Financial Statement Overview
Summary
Income Statement
Balance Sheet
Cash Flow
| Breakdown | ||||
| Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|
| Income Statement | Total Revenue | |||
| 164.22M | 113.54M | 173.56M | 181.61M | 83.93M | Gross Profit |
| 111.05M | 77.16M | 114.57M | 115.24M | 56.53M | EBIT |
| 13.15M | -312.59M | 15.99M | 40.86M | 114.00K | EBITDA |
| 22.79M | -305.61M | 19.10M | 43.99M | 701.00K | Net Income Common Stockholders |
| 16.83M | -321.95M | 8.36M | 32.83M | -1.74M |
| Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
| 68.74M | 44.15M | 48.06M | 52.40M | 4.33M | Total Assets |
| 350.84M | 313.78M | 621.90M | 550.69M | 57.64M | Total Debt |
| 3.02M | 3.89M | 1.64M | 2.40M | 1.66M | Net Debt |
| -65.71M | -40.11M | -46.42M | -50.00M | -2.66M | Total Liabilities |
| 31.23M | 22.53M | 29.34M | 31.54M | 30.16M | Stockholders Equity |
| 319.61M | 291.25M | 592.56M | 519.15M | 27.48M |
| Cash Flow | Free Cash Flow | |||
| 22.75M | -4.27M | -50.64M | 34.15M | 1.03M | Operating Cash Flow |
| 24.34M | 3.79M | -1.54M | 37.60M | 2.92M | Investing Cash Flow |
| -1.59M | -9.42M | -52.11M | -407.47M | -4.04M | Financing Cash Flow |
| -1.38M | 1.95M | 47.50M | 416.27M | 694.00K |
Polygiene AB Technical Analysis
Negative
9.86
Price Trends
10.83
Negative
11.93
Negative
11.25
Negative
Market Momentum
-0.28
Negative
41.30
Neutral
28.48
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:POLYG, the sentiment is Negative. The current price of 9.86 is below the 20-day moving average (MA) of 9.90, below the 50-day MA of 10.83, and below the 200-day MA of 11.25, indicating a bearish trend. The MACD of -0.28 indicates Negative momentum. The RSI at 41.30 is Neutral, neither overbought nor oversold. The STOCH value of 28.48 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SE:POLYG.
Polygiene AB Peers Comparison
Overall Rating
UnderperformOutperform
Sector (64)
Financial Indicators
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
67 Neutral | kr361.62M | 28.16 | 4.19% | ― | 38.77% | ― | |
64 Neutral | $9.21B | 14.61 | 4.29% | 186.43% | 3.98% | 5.57% | |
49 Neutral | kr74.19M | ― | -29.75% | ― | 373.74% | 46.13% | |
48 Neutral | €204.98M | ― | -15.65% | ― | -10.46% | -680.00% | |
44 Neutral | €237.08M | ― | -5.94% | ― | 2.29% | 45.77% | |
44 Neutral | kr215.86M | ― | -47.96% | ― | -12.78% | -13.79% | |
31 Underperform | kr86.35M | ― | ― | 16.48% | -9.56% |
* Consumer Defensive Sector Average
Performance Comparison
SE:POLYG
Polygiene AB
9.68
0.18
1.89%
SE:AXIC.A
aXichem AB Class A
1.27
0.07
5.86%
SE:LCLEAN
LifeClean International AB
0.24
-4.39
-94.76%
SE:NEXAM
Nexam Chemical Holding AB
3.30
0.29
9.63%
SE:ORGC
OrganoClick AB
2.20
-0.85
-27.87%
SE:SERT
Serstech AB
0.79
-0.44
-35.91%
Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.